Beijing, China

Guochao Liao

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guochao Liao. Retrieved from https://idiyas.com/inventor/guochao-liao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guochao Liao: Innovator in Neurodegenerative Disease Treatment

Introduction

Guochao Liao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at treating chronic neurodegenerative diseases.

Latest Patents

Liao holds a patent for "Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors." This invention relates to compounds represented by a specific formula, including isomers, prodrugs, pharmaceutically acceptable salts, solvates, or hydrates. The compounds are designed for treating conditions such as Alzheimer's disease and other disorders associated with the aggregation or deposition of β-amyloid peptide.

Career Highlights

Guochao Liao is affiliated with the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences, PLA China. His work focuses on innovative solutions for complex medical challenges, particularly in neurodegenerative diseases.

Collaborations

Liao collaborates with notable colleagues, including Song Li and Junhai Xiao, to advance research and development in his field.

Conclusion

Guochao Liao's contributions to pharmacology and his innovative patent for beta-secretase inhibitors highlight his commitment to addressing critical health issues. His work continues to pave the way for advancements in the treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…